All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Reported results | 2004-000919-26 | Phase II, randomized, pharmokinetic, dose finding, and dose frequency determination using rt-PA in intraventricular hemorrhage | 2008-08-21 | due-trials |
Reported results | 2007-006006-22 | Minimally Invasive Surgery plus rt-PA for ICH Evacuation | 2014-09-02 | due-trials |
No trial status on register | 2008-005571-10 | DEXTROMETORPHAN IN RETT SYNDROME | bad-data | |
Reported results | 2008-006916-39 | CLEAR III. Clot lysis: evaluating accelerated resolution of intraventricular hemorrhage | 2016-05-02 | due-trials |
Reported results | 2013-002818-12 | A phase III, randomized, open-label, 500-subject clinical trial of minimally invasive surgery plus rt-PA in the treatment of intracerebral haemorrhage. | 2019-01-28 | due-trials |
Exempt | 2013-003184-62 | A phase I study of SGI-110 combined with irinotecan followed by a randomized phase II study of SGI-110 combined with irinotecan versus regorafenib in previously treated metastatic colorectal cancer pa... | 2018-10-24 | not-yet-due |
Ongoing | 2013-005086-40 | A multi-institutional open label, trial evaluating the efficacy of Gemcitabine and Docetaxel in patients with relapsed or refractory metastatic colorectal adenocarcinoma with methylated CHFR and/or mi... | not-yet-due | |
Listed as ongoing, but also has a completion date and reported results | 2015-001776-21 | Prospective Multi-Center Evaluation of the Duration of Therapy for Thrombosis in Children | 2021-12-31 | bad-data |
Reported results Terminated | 2016-000304-29 | Periocular and Intravitreal Corticosteroids for Uveitic Macular Edema (POINT) Trial | 2018-03-28 | due-trials |
Other | 2017-003243-37 | Macular Edema Ranibizumab v. Intravitreal anti-inflammatory Therapy (MERIT) Trial | not-yet-due | |
Other | 2019-002366-12 | ADalimumab Vs. conventional ImmunoSupprEssion for uveitis (ADVISE)Trial | not-yet-due |